CuraTeQ Biologics (a wholly owned subsidiary of Aurobindo Pharma Ltd.) is a biopharmaceutical company based out of Hyderabad, India. Our vision is to improve the wellbeing of patients suffering from debilitating illnesses by providing them access to high quality and cost-effective biosimilars. CuraTeQ has a development pipeline of 14 biosimilars, of which, two products have been filed with EMA and three more products are in global phase 3 clinical trials. Our Mission: ● Deliver exceptional value to stakeholders and better health outcomes to patients by becoming a leading global biosimilars developer by 2030. ● Build deep capabilities in development and manufacturing to deliver quality and cost-effective biosimilars for patients across the globe. ● Create a sustainable and broad portfolio of biosimilars with a focus on oncology and immunology therapies.